This contract expires in 98 days (Jul 23, 2026).
SHERLOCK BIOSCIENCES, INC. - DEVELOPMENT OF A LOW-COST, POINT-OF-NEED MOLECULAR TEST FOR FLU A+B AND SELF-COLLECTED SWAB SPECIMENS.
Key Details
Description
DEVELOPMENT OF A LOW-COST, POINT-OF-NEED MOLECULAR TEST FOR FLU A+B AND SELF-COLLECTED SWAB SPECIMENS.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.